XWELL, Inc. (XWEL)
- Previous Close
1.7825 - Open
1.8400 - Bid --
- Ask --
- Day's Range
1.7950 - 1.8750 - 52 Week Range
1.2600 - 6.4000 - Volume
8,008 - Avg. Volume
12,731 - Market Cap (intraday)
7.53M - Beta (5Y Monthly) 2.45
- PE Ratio (TTM)
-- - EPS (TTM)
-6.6400 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.00
XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
www.xwell.com266
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: XWEL
Performance Overview: XWEL
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: XWEL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: XWEL
Valuation Measures
Market Cap
7.53M
Enterprise Value
-4.43M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.25
Price/Book (mrq)
0.58
Enterprise Value/Revenue
-0.15
Enterprise Value/EBITDA
0.28
Financial Highlights
Profitability and Income Statement
Profit Margin
-92.14%
Return on Assets (ttm)
-22.04%
Return on Equity (ttm)
-81.34%
Revenue (ttm)
30.11M
Net Income Avi to Common (ttm)
-27.74M
Diluted EPS (ttm)
-6.6400
Balance Sheet and Cash Flow
Total Cash (mrq)
23.05M
Total Debt/Equity (mrq)
52.90%
Levered Free Cash Flow (ttm)
-8.38M